成人2型糖尿病基础胰岛素临床应用中国专家指导建议(2020版)

2020-10-30 中国内分泌相关专家小组(统称) 中国糖尿病杂志.2020.28(10):721-728.

T2DM 患者随着病情进展,胰岛β 细胞功能减退,需要胰岛素治疗以达到有效的血糖控制。基础胰岛素是T2DM 治疗的重要药物之一,当前我国存在基础胰岛素治疗存在起始治疗较晚,起始剂量偏低且剂量

中文标题:

成人2型糖尿病基础胰岛素临床应用中国专家指导建议(2020版)

发布日期:

2020-10-30

简要介绍:

T2DM 患者随着病情进展,胰岛β 细胞功能减退,需要胰岛素治疗以达到有效的血糖控制。基础胰岛素是T2DM 治疗的重要药物之一,当前我国存在基础胰岛素治疗存在起始治疗较晚,起始剂量偏低且剂量调整不足等情况。为规范基础胰岛素在临床中的合理使用,我国部分内分泌、糖尿病学界专家于2017 年制订了《成人2 型糖尿病基础胰岛素临床应用中国专家指导建议》,基于循证证据对基础胰岛素常用临床方案的适用人群、起始方法、剂量调整方法等做出推荐。本次修订针对基础胰岛素应用的临床证据进行更新。

相关资料下载:
[AttachmentFileName(sort=1, fileName=成人2型糖尿病基础胰岛素临床应用中国专家指导建议_2020版_冉兴无.pdf)] GetToolGuiderByIdResponse(projectId=1, id=c84141c002008a6a, title=成人2型糖尿病基础胰岛素临床应用中国专家指导建议(2020版), enTitle=, guiderFrom=中国糖尿病杂志.2020.28(10):721-728., authorId=0, author=, summary=T2DM 患者随着病情进展,胰岛&beta; 细胞功能减退,需要胰岛素治疗以达到有效的血糖控制。基础胰岛素是T2DM 治疗的重要药物之一,当前我国存在基础胰岛素治疗存在起始治疗较晚,起始剂量偏低且剂量, cover=https://img.medsci.cn/20201114/1605369087060_2020535.jpg, journalId=0, articlesId=null, associationId=666, associationName=中国内分泌相关专家小组(统称), associationIntro=这是一个统称,其下指南和专家共识均由国内内分泌领域的专家制定。, copyright=0, guiderPublishedTime=Fri Oct 30 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>T2DM 患者随着病情进展,胰岛&beta; 细胞功能减退,需要胰岛素治疗以达到有效的血糖控制。基础胰岛素是T2DM 治疗的重要药物之一,当前我国存在基础胰岛素治疗存在起始治疗较晚,起始剂量偏低且剂量调整不足等情况。为规范基础胰岛素在临床中的合理使用,我国部分内分泌、糖尿病学界专家于2017 年制订了《成人2 型糖尿病基础胰岛素临床应用中国专家指导建议》,基于循证证据对基础胰岛素常用临床方案的适用人群、起始方法、剂量调整方法等做出推荐。本次修订针对基础胰岛素应用的临床证据进行更新。</p> </div> </div> </div>, tagList=[TagDto(tagId=217, tagName=胰岛素), TagDto(tagId=2052, tagName=2型糖尿病)], categoryList=[CategoryDto(categoryId=6, categoryName=内分泌科, tenant=100), CategoryDto(categoryId=8, categoryName=糖尿病, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=2052, guiderKeyword=2型糖尿病, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=13281, appHits=993, showAppHits=0, pcHits=1466, showPcHits=12288, likes=10, shares=115, comments=54, approvalStatus=1, publishedTime=Sun Nov 15 00:11:14 CST 2020, publishedTimeString=2020-10-30, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sat Nov 14 23:51:37 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 04:00:18 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=成人2型糖尿病基础胰岛素临床应用中国专家指导建议_2020版_冉兴无.pdf)])
成人2型糖尿病基础胰岛素临床应用中国专家指导建议_2020版_冉兴无.pdf
下载请点击:
评论区 (43)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1209636, encodeId=43121209636d6, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dec22608622, createdName=gujie_happy, createdTime=Fri Apr 08 19:21:35 CST 2022, time=2022-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053179, encodeId=914110531e982, content=有没有各类胰岛素的比较?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/TG0llFIicHDkEWTWfibxX1Iv4uEMOibZWuq5kSbiamdmtvHenurlZXRBz5pa4ezDZIu01MFv18EZy1nsLD9BGtGIKg/132, createdBy=51b75309464, createdName=meisiyixue, createdTime=Mon Sep 20 08:28:42 CST 2021, time=2021-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012739, encodeId=a2391012e39a4, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28735519732, createdName=ms3000001491842979, createdTime=Mon Aug 30 08:19:58 CST 2021, time=2021-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012738, encodeId=8f7c1012e38ca, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28735519732, createdName=ms3000001491842979, createdTime=Mon Aug 30 08:18:19 CST 2021, time=2021-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012737, encodeId=a1c81012e37db, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28735519732, createdName=ms3000001491842979, createdTime=Mon Aug 30 08:17:54 CST 2021, time=2021-08-30, status=1, ipAttribution=)]
    2022-04-08 gujie_happy

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1209636, encodeId=43121209636d6, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dec22608622, createdName=gujie_happy, createdTime=Fri Apr 08 19:21:35 CST 2022, time=2022-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053179, encodeId=914110531e982, content=有没有各类胰岛素的比较?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/TG0llFIicHDkEWTWfibxX1Iv4uEMOibZWuq5kSbiamdmtvHenurlZXRBz5pa4ezDZIu01MFv18EZy1nsLD9BGtGIKg/132, createdBy=51b75309464, createdName=meisiyixue, createdTime=Mon Sep 20 08:28:42 CST 2021, time=2021-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012739, encodeId=a2391012e39a4, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28735519732, createdName=ms3000001491842979, createdTime=Mon Aug 30 08:19:58 CST 2021, time=2021-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012738, encodeId=8f7c1012e38ca, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28735519732, createdName=ms3000001491842979, createdTime=Mon Aug 30 08:18:19 CST 2021, time=2021-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012737, encodeId=a1c81012e37db, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28735519732, createdName=ms3000001491842979, createdTime=Mon Aug 30 08:17:54 CST 2021, time=2021-08-30, status=1, ipAttribution=)]
    2021-09-20 meisiyixue

    有没有各类胰岛素的比较?

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1209636, encodeId=43121209636d6, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dec22608622, createdName=gujie_happy, createdTime=Fri Apr 08 19:21:35 CST 2022, time=2022-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053179, encodeId=914110531e982, content=有没有各类胰岛素的比较?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/TG0llFIicHDkEWTWfibxX1Iv4uEMOibZWuq5kSbiamdmtvHenurlZXRBz5pa4ezDZIu01MFv18EZy1nsLD9BGtGIKg/132, createdBy=51b75309464, createdName=meisiyixue, createdTime=Mon Sep 20 08:28:42 CST 2021, time=2021-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012739, encodeId=a2391012e39a4, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28735519732, createdName=ms3000001491842979, createdTime=Mon Aug 30 08:19:58 CST 2021, time=2021-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012738, encodeId=8f7c1012e38ca, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28735519732, createdName=ms3000001491842979, createdTime=Mon Aug 30 08:18:19 CST 2021, time=2021-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012737, encodeId=a1c81012e37db, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28735519732, createdName=ms3000001491842979, createdTime=Mon Aug 30 08:17:54 CST 2021, time=2021-08-30, status=1, ipAttribution=)]
    2021-08-30 ms3000001491842979

    很好

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1209636, encodeId=43121209636d6, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dec22608622, createdName=gujie_happy, createdTime=Fri Apr 08 19:21:35 CST 2022, time=2022-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053179, encodeId=914110531e982, content=有没有各类胰岛素的比较?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/TG0llFIicHDkEWTWfibxX1Iv4uEMOibZWuq5kSbiamdmtvHenurlZXRBz5pa4ezDZIu01MFv18EZy1nsLD9BGtGIKg/132, createdBy=51b75309464, createdName=meisiyixue, createdTime=Mon Sep 20 08:28:42 CST 2021, time=2021-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012739, encodeId=a2391012e39a4, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28735519732, createdName=ms3000001491842979, createdTime=Mon Aug 30 08:19:58 CST 2021, time=2021-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012738, encodeId=8f7c1012e38ca, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28735519732, createdName=ms3000001491842979, createdTime=Mon Aug 30 08:18:19 CST 2021, time=2021-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012737, encodeId=a1c81012e37db, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28735519732, createdName=ms3000001491842979, createdTime=Mon Aug 30 08:17:54 CST 2021, time=2021-08-30, status=1, ipAttribution=)]
    2021-08-30 ms3000001491842979

    很好

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1209636, encodeId=43121209636d6, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dec22608622, createdName=gujie_happy, createdTime=Fri Apr 08 19:21:35 CST 2022, time=2022-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053179, encodeId=914110531e982, content=有没有各类胰岛素的比较?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/TG0llFIicHDkEWTWfibxX1Iv4uEMOibZWuq5kSbiamdmtvHenurlZXRBz5pa4ezDZIu01MFv18EZy1nsLD9BGtGIKg/132, createdBy=51b75309464, createdName=meisiyixue, createdTime=Mon Sep 20 08:28:42 CST 2021, time=2021-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012739, encodeId=a2391012e39a4, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28735519732, createdName=ms3000001491842979, createdTime=Mon Aug 30 08:19:58 CST 2021, time=2021-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012738, encodeId=8f7c1012e38ca, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28735519732, createdName=ms3000001491842979, createdTime=Mon Aug 30 08:18:19 CST 2021, time=2021-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012737, encodeId=a1c81012e37db, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28735519732, createdName=ms3000001491842979, createdTime=Mon Aug 30 08:17:54 CST 2021, time=2021-08-30, status=1, ipAttribution=)]
    2021-08-30 ms3000001491842979

    很好

    0

拓展阅读

2014 ADS立场声明:2型糖尿病血糖管理法则

澳大利亚糖尿病协会(ADS,Australian Diabetes Society) · 2014-12-11

2015 AHA/ADA科学声明:成人2型糖尿病患者心血管疾病的预防(更新版)

美国糖尿病学会(ADA,American Diabetes Association) · 2015-08-05

2015 ADA/AADE/AND联合声明:2型糖尿病的自我管理教育和支持

美国糖尿病学会(ADA,American Diabetes Association) · 2015-06-05

2013 中国2型糖尿病防治指南(2013年版)

中华医学会糖尿病学分会(CDS,Chinese Diabetes Society) · 2014-08-16